- Report
- August 2022
Global
From €992EUR$1,090USD£850GBP
- Report
- August 2022
Global
From €719EUR$790USD£616GBP
- Report
- August 2022
Global
From €719EUR$790USD£616GBP
- Report
- August 2024
- 94 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- February 2024
- 102 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- May 2022
- 92 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- December 2022
- 60 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- May 2022
- 176 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- May 2022
- 92 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- May 2022
- 105 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- May 2022
- 81 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- November 2021
- 620 Pages
Global
From €3640EUR$4,000USD£3,121GBP
The Influenza Drug market is a subset of the larger Respiratory Drug market, which includes treatments for a variety of respiratory illnesses, such as asthma, COPD, and cystic fibrosis. Influenza drugs are used to treat the symptoms of the flu, such as fever, cough, and sore throat. These drugs can also help reduce the risk of complications from the flu, such as pneumonia. Commonly used influenza drugs include antivirals, such as oseltamivir and zanamivir, and anti-inflammatory drugs, such as ibuprofen and acetaminophen.
Some companies in the Influenza Drug market include GlaxoSmithKline, Sanofi, Novartis, and AstraZeneca. Other companies include Roche, Merck, and Pfizer. Show Less Read more